1/2
08:30 am
cdt
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
High
Report
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
12/3
04:28 pm
cdt
CDT Equity (NASDAQ:CDT) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
CDT Equity (NASDAQ:CDT) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.